Related Experiment Video
Updated: Apr 12, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Actual drug allergy during childhood: Five years' experience at a tertiary referral centre
G D Tugcu1, O Cavkaytar2, B E Sekerel2
1Hacettepe University, School of Medicine, Department of Pediatrics, 06100 Ankara, Turkey.
Insights
Actual drug allergy in children is confirmed in 17.7% of suspected cases. History of anaphylaxis, sweating, and dyspnea during reactions increase the risk for true drug allergies.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Immunology
- Pharmacovigilance
Background:
- Drug hypersensitivity reactions (DHR) are prevalent in children, often overestimated by caregivers and physicians.
- Accurate diagnosis of pediatric drug allergy is crucial for public health.
- Tertiary referral centers play a key role in evaluating complex DHR cases.
Purpose of the Study:
- To determine the prevalence of actual drug allergies in children presenting with suspected DHR.
- To identify risk factors associated with confirmed drug allergies in pediatric patients.
- To differentiate between perceived and actual drug allergies in a clinical setting.
Main Methods:
- Retrospective review of medical records (2005-2010) for children with a history of DHR.
- Utilized European Network for Drug Allergy (ENDA) questionnaires via medical records and parent interviews.
- Conducted skin and drug provocation tests to confirm allergic reactions.
Main Results:
- Out of 96 patients with 140 DHRs, 17.7% (17 children) had confirmed drug allergy.
- Confirmed drug allergy was more frequent in children with chronic diseases (58.8%) and a history of anaphylaxis (58.8%).
- Anaphylaxis history (OR: 5.789), sweating (OR: 7.8), and dyspnea (OR: 5.230) during DHRs significantly increased the risk for actual drug allergy.
Conclusions:
- Actual drug allergy was confirmed in 17.7% of pediatric patients with suspected DHRs.
- History of anaphylaxis, sweating, and dyspnea are significant indicators of increased risk for actual drug allergy.
- Accurate diagnostic testing is essential for identifying true drug allergies and managing pediatric DHRs.
Background:
Drug hypersensitivity reactions (DHR) are common in the paediatric population, representing a public health problem. Recent studies have confirmed that the frequency of drug allergy is overestimated by both parents and physicians. The aim of this study is to determine the prevalence and risk factors of actual drug allergies in children admitted to a tertiary referral allergy centre.
Methods:
Medical records covering the period of 2005-2010 of children with a history of DHR were reviewed. Demographic features of the patients and results of skin and drug provocation tests were noted. The European Network for Drug Allergy (ENDA) questionnaire was filled by using medical records and making phone calls with parents.
Results:
Ninety-six patients with 140 DHRs were evaluated. Seventeen children had confirmed drug allergy by positive skin tests (n=11) and drug provocation tests (n=5). One patient underwent severe anaphylaxis and subsequent cardiac arrest during infusion of the drug, and therefore diagnostic tests were not performed. Actual drug allergy was more frequent in children with chronic diseases (58.8% vs. 26.5%, p=0.018) and histories of anaphylaxis during DHR (58.8% vs. 24%, p=0.001). The patients' history of anaphylaxis [OR: 5.789, 95%CI: 1.880-17.554, p=0.002], sweating [OR: 7.8, 95%CI: 1.041-58.443, p=0.046] and dyspnoea [OR: 5.230, 95%CI: 1.836-14.894, p=0.002] during suspicious DHRs increased the risk for actual drug allergy.
Conclusion:
Actual drug allergy was determined in 17.7% of the patients with a suspicious DHR. Having a history of anaphylaxis during suspected drug reactions as well as symptoms of sweating and dyspnoea increased the risk for actual drug allergy.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

